121 related articles for article (PubMed ID: 38181691)
41. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
[TBL] [Abstract][Full Text] [Related]
42. Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme.
Heidenreich A; Scholz HJ; Rogenhofer S; Arsov C; Retz M; Müller SC; Albers P; Gschwend J; Wirth M; Steiner U; Miller K; Heinrich E; Trojan L; Volkmer B; Honecker F; Bokemeyer C; Keck B; Otremba B; Ecstein-Fraisse E; Pfister D
Eur Urol; 2013 Jun; 63(6):977-82. PubMed ID: 23116658
[TBL] [Abstract][Full Text] [Related]
43. Photodynamic therapy of prostate cancer using porphyrinic formulations.
Mesquita MQ; Ferreira AR; Neves MDGPMS; Ribeiro D; Fardilha M; Faustino MAF
J Photochem Photobiol B; 2021 Oct; 223():112301. PubMed ID: 34492530
[TBL] [Abstract][Full Text] [Related]
44. Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with various efficacy and toxicity.
Jarvis C; Nelius T; Martinez-Marin D; Sennoune SR; Filleur S
Prostate; 2018 Sep; 78(12):905-914. PubMed ID: 29749077
[TBL] [Abstract][Full Text] [Related]
45. Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression.
Jang YG; Ko EB; Choi KC
J Nutr Biochem; 2020 Oct; 84():108444. PubMed ID: 32615369
[TBL] [Abstract][Full Text] [Related]
46. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.
Jackson RS; Placzek W; Fernandez A; Ziaee S; Chu CY; Wei J; Stebbins J; Kitada S; Fritz G; Reed JC; Chung LW; Pellecchia M; Bhowmick NA
Neoplasia; 2012 Jul; 14(7):656-65. PubMed ID: 22904682
[TBL] [Abstract][Full Text] [Related]
47. The synergistic anticancer effect of salinomycin combined with cabazitaxel in CD44+ prostate cancer cells by downregulating wnt, NF-κB and AKT signaling.
Erdogan S; Serttas R; Turkekul K; Dibirdik I
Mol Biol Rep; 2022 Jun; 49(6):4873-4884. PubMed ID: 35705771
[TBL] [Abstract][Full Text] [Related]
48. BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis.
Seo SI; Gera L; Zhau HE; Qian WP; Iqbal S; Johnson NA; Zhang S; Zayzafoon M; Stewart J; Wang R; Chung LW; Wu D
Clin Cancer Res; 2008 Oct; 14(19):6198-206. PubMed ID: 18829499
[TBL] [Abstract][Full Text] [Related]
49. Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancer.
Kommineni N; Saka R; Bulbake U; Khan W
Chem Phys Lipids; 2019 Nov; 224():104707. PubMed ID: 30521787
[TBL] [Abstract][Full Text] [Related]
50. NSC606985, a novel camptothecin analog, induces apoptosis and growth arrest in prostate tumor cells.
Tan C; Cai LQ; Wu W; Qiao Y; Imperato-McGinley J; Chen GQ; Zhu YS
Cancer Chemother Pharmacol; 2009 Jan; 63(2):303-12. PubMed ID: 18373093
[TBL] [Abstract][Full Text] [Related]
51. Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience.
Francini E; Fiaschi AI; Petrioli R; Laera L; Bianco V; Ponchietti R; Roviello G
Anticancer Drugs; 2015 Sep; 26(8):884-7. PubMed ID: 26053281
[TBL] [Abstract][Full Text] [Related]
52. Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines.
Chand P; Kumar H; Badduri N; Gupta NV; Bettada VG; Madhunapantula SV; Kesharwani SS; Dey S; Jain V
Colloids Surf B Biointerfaces; 2021 Mar; 199():111535. PubMed ID: 33360926
[TBL] [Abstract][Full Text] [Related]
53. Immunotherapeutic role of cabazitaxel treatment in the activation of TLR3 signalling in metastatic castration-resistant prostate cancer in vitro.
Deveci Ozkan A; Guney Eskiler G; Kaleli S; Sahin E
Mol Biol Rep; 2022 Feb; 49(2):1261-1271. PubMed ID: 34826050
[TBL] [Abstract][Full Text] [Related]
54. EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage.
Kuroda S; Tam J; Roth JA; Sokolov K; Ramesh R
Int J Nanomedicine; 2014; 9():3825-39. PubMed ID: 25143731
[TBL] [Abstract][Full Text] [Related]
55. Synthesis of Silica Based Nanoparticles Against the Proliferation of Human Prostate Cancer.
Durmus IM; Deveci I; Karakurt S
Anticancer Agents Med Chem; 2021; 21(18):2553-2562. PubMed ID: 33557739
[TBL] [Abstract][Full Text] [Related]
56. Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer.
Mout L; van Royen ME; de Ridder C; Stuurman D; van de Geer WS; Marques R; Buck SAJ; French PJ; van de Werken HJG; Mathijssen RHJ; de Wit R; Lolkema MP; van Weerden WM
EBioMedicine; 2021 Nov; 73():103681. PubMed ID: 34749299
[TBL] [Abstract][Full Text] [Related]
57. Sequential MR Image-Guided Local Immune Checkpoint Blockade Cancer Immunotherapy Using Ferumoxytol Capped Ultralarge Pore Mesoporous Silica Carriers after Standard Chemotherapy.
Choi B; Jung H; Yu B; Choi H; Lee J; Kim DH
Small; 2019 Dec; 15(52):e1904378. PubMed ID: 31697036
[TBL] [Abstract][Full Text] [Related]
58. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
Yallapu MM; Khan S; Maher DM; Ebeling MC; Sundram V; Chauhan N; Ganju A; Balakrishna S; Gupta BK; Zafar N; Jaggi M; Chauhan SC
Biomaterials; 2014 Oct; 35(30):8635-48. PubMed ID: 25028336
[TBL] [Abstract][Full Text] [Related]
59. [Induction of apoptosis in prostate cancer cell line PC-3 by BBSKE, a novel organoselenium compound, and its effect in vivo].
Shi CJ; Zeng HH; Li HW; Yang FG; Wu XQ; Yu LZ
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1984-8. PubMed ID: 14703435
[TBL] [Abstract][Full Text] [Related]
60. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
Nagesh PKB; Johnson NR; Boya VKN; Chowdhury P; Othman SF; Khalilzad-Sharghi V; Hafeez BB; Ganju A; Khan S; Behrman SW; Zafar N; Chauhan SC; Jaggi M; Yallapu MM
Colloids Surf B Biointerfaces; 2016 Aug; 144():8-20. PubMed ID: 27058278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
